Hospital and Pre-Hospital External Defibrillator Market Expected to Reach $5.5 Billion by 2035

According to a new report published by Allied Market Research, titled, “Hospital and Pre-Hospital External Defibrillator Market," The hospital and pre-hospital external defibrillator market size was valued at $2.7 billion in 2023, and is estimated to reach $5.5 billion by 2035, growing at a CAGR of 6.1% from 2024 to 2035.

A hospital and pre-hospital external defibrillator is a life-saving medical device designed to restore normal heart rhythm in patients experiencing sudden cardiac arrest (SCA). These devices deliver controlled electrical shocks to the heart to stop abnormal rhythms, such as Ventricular fibrillation or pulseless Ventricular tachycardia. In hospital settings, manual defibrillators are used by healthcare professionals to administer precise shocks based on real-time cardiac monitoring.

In pre-hospital environments, automated external defibrillators (AEDs) are widely used by emergency medical services (EMS) and first responders. AEDs analyze heart rhythms and provide voice or visual prompts to guide users through defibrillation. Modern defibrillators feature real-time ECG monitoring, self-diagnostic capabilities, and connectivity for remote patient management, ensuring rapid and effective treatment in critical situations.

The hospital and pre-hospital external defibrillator market growth is driven by rise in prevalence of cardiovascular diseases (CVDs), favorable reimbursement policies, and increasing product launches by key market players. Cardiovascular diseases remain the leading cause of mortality worldwide, prompting surge in adoption of external defibrillators for emergency response and patient management. The growing prevalence of heart-related conditions, including cardiac arrests and arrhythmias, has increased the demand for both manual and automated external defibrillators (AEDs) in hospitals, ambulances, and public spaces.

Moreover, favorable reimbursement policies significantly contribute to market expansion by lowering financial barriers for both healthcare providers and patients. In many countries, healthcare systems offer partial or full reimbursement for defibrillators, enhancing affordability and facilitating wider integration of defibrillator into clinical settings. This has resulted in a substantial increase in defibrillator installations in hospitals, where these devices are essential for effective execution of Advanced Cardiac Life Support (ACLS) protocols, thereby driving the hospital and pre-hospital external defibrillator market growth.

In addition, continuous innovation, and product launches by leading medical device companies are further fueling market growth. For instance, in June 2024, Stryker introduced the LIFEPAK 35 monitor/defibrillator, designed to offer advanced technology in an intuitive and modern platform to improve patient care. The device provides real-time patient data access, assisting healthcare teams in making critical decisions efficiently. Such innovations help enhance emergency response capabilities, improve patient survival rates, and support healthcare professionals dealing with burnout and high-pressure environments.

Thus, with rise in incidences of CVDs, government-backed reimbursement programs, and technological advancements, the hospital and pre-hospital external defibrillator market opportunity is poised for robust growth. These factors collectively strengthen emergency medical infrastructure, ensuring timely and effective interventions for cardiac emergencies across healthcare settings.

The hospital and pre-hospital external defibrillator industry is segmented into type, end user, and region. On the basis of type, it is segmented into manual external defibrillator, automated external defibrillator, and wearable cardioverter defibrillators. The automated external defibrillator segment dominated the market share in 2023, owing to its ease of use, increasing public access initiatives, and surge in adoption in non-medical settings such as airports, schools, and shopping malls.

Government regulations mandating AED installations, along with rise in awareness programs on sudden cardiac arrest (SCA) management, are further anticipated to drive the demand for the defibrillator installations. In addition, technological advancements improving AED accuracy and usability contribute to the hospital and pre-hospital external defibrillator industry growth.

However, the wearable cardioverter defibrillators segment is expected to register the highest CAGR during the forecast period, owing to rise in prevalence of sudden cardiac arrest (SCA) and increase in adoption of wearable technologies for continuous cardiac monitoring. Advancements in device miniaturization, improved battery life, and integration with remote monitoring systems further contribute to the market growth. In addition, rise in awareness and favorable reimbursement policies support wider adoption of external defibrillator among high-risk patients.

On the basis of end user, it is classified into hospitals, pre-hospitals, and public access defibrillator (PAD). The hospitals segment dominated the hospital and pre-hospital external defibrillator market size in 2023, owing to the high volume of emergency cases, advanced healthcare infrastructure, and the presence of well-equipped cardiac care units (CCUs). Hospitals require continuous availability of external defibrillators for critical care, surgical procedures, and emergency response teams, leading to higher adoption. In addition, favorable reimbursement policies, increasing prevalence of cardiovascular diseases (CVDs), and the presence of skilled healthcare professionals further contributed to the segment’s dominance.

However, the public access defibrillator (PAD) segment is expected to register the highest CAGR during the forecast period, owing to increasing government initiatives to install AEDs in public spaces, rise in awareness about sudden cardiac arrest (SCA), and widespread training programs on CPR and AED usage. In addition, technological advancements in user-friendly, AI-integrated defibrillators and rise in presence of PAD programs in workplaces, airports, and educational institutions further drive hospital and pre-hospital external defibrillator market trends.

Region-wise, North America was the largest shareholder in the hospital and pre-hospital external defibrillator market analysis in 2023, owing to its advanced healthcare infrastructure, high prevalence of cardiovascular diseases (CVDs), and strong presence of key market players. The widespread adoption of automated external defibrillators (AEDs) in public places, coupled with favorable reimbursement policies and government initiatives for cardiac emergency preparedness, further contributed to market dominance. In addition, increased investments in emergency medical services (EMS) and technological advancements in defibrillators have bolstered market growth in the region.

However, Asia-Pacific is anticipated to register the highest CAGR during the hospital and pre-hospital external defibrillator market forecast period, owing to rise in incidence of cardiovascular diseases (CVDs), growing geriatric population, and increasing healthcare investments. Expanding emergency medical services (EMS), improving healthcare infrastructure, and rise in awareness about automated external defibrillators (AEDs) are expected to drive the market growth in the region. In addition, government initiatives, increasing adoption of advanced medical devices, and rise in presence of key market players contribute to the region’s rapid market expansion.

Key findings of the study

• On the basis of type, the automated external defibrillator segment dominated the hospital and pre-hospital external defibrillator market share in 2023. However, the wearable cardioverter defibrillator segment is anticipated to grow at the highest CAGR during the forecast period.
• On the basis of end user, the hospitals segment dominated the hospital and pre-hospital external defibrillator market share in 2023. However, public access defibrillator (PAD) segment is anticipated to grow at the highest CAGR during the forecast period.
• Region-wise, North America generated the largest revenue in 2023. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.